P/E Ratio
Price-to-earnings ratio, a valuation metric.
Latest P/E Ratio: 32.7 (2026Q1); -51.1% YoY.
Revenue
EPS
Free Cash Flow
Gross Margin
FCF Margin
P/E Ratio
Cumulative FCF
Shares Outstanding
Rule of 40
Quarterly P/E Ratio Data
| Period | Value |
|---|---|
| 2024Q1 | 114.2 |
| 2024Q2 | 111.0 |
| 2024Q3 | 95.3 |
| 2024Q4 | 65.6 |
| 2025Q1 | 66.8 |
| 2025Q2 | 50.7 |
| 2025Q3 | 37.2 |
| 2025Q4 | 46.6 |
| 2026Q1 | 32.7 |
Healthcare Comparison
1 / 3
Other LLY Charts
More quarter-by-quarter fundamentals for Eli Lilly and Company
1 / 8